Brudy Hepato

Brudy Hepato
Product Description

Brudy Hepato is a product design for fatty liver disease. Our Clinical Trials and publications in the TOP medical magazines, have demonstrated that the product is able to reduce the portal vein pressure, which it shows an anti-inflammatory effect in the liver. The product it is based in a specific molecule of Omega-3 DHA.

BRUDY LAB S.L.U.

  • ES
  • 2022
    On CPHI since
  • 2
    Certificates
  • 50 - 99
    Employees
Company types
Distributor/Import Export
Manufacturer/Innovator
Pharmaceutical company
Specifications

BRUDY LAB S.L.U.

  • ES
  • 2022
    On CPHI since
  • 2
    Certificates
  • 50 - 99
    Employees
Company types
Distributor/Import Export
Manufacturer/Innovator
Pharmaceutical company

More Products from BRUDY LAB S.L.U. (4)

  • Brudy Neo

    Product Brudy Neo

    Brudy Neo is a product designed for early-birth babies. All of them require a special attention and nutrients, which they lack due to their shorter pregnancy period. This product give them the require dosage of Omega-3 DHA, needed for the correct development of the brain and the eyes, among other parts. It...
  • Brudy Gyne Dry

    Product Brudy Gyne Dry

    Food supplement for vaginal dryness. The product has been tested in one of the biggest hospital groups. The test length was 3 months and it had a 100% satisfaction in less than a month.The results were seen in less than a month and for the worst cases, was consider a life changer.
  • Brudy Macula

    Product Brudy Macula

    Brudy Macula is a food supplement based in our molecule of Omega-3, designed for the macular degeneration (AMD)(Ophthalmology).This is one of our best selling products in several countries around the world, because it has proven high efficiency.The product it is supported by the AREDS 2 Clinical Trial.
  • Brudy Pio

    Product Brudy Pio

    Product for glaucoma pathologies (Ophthalmology). The product has been tested in different Clinical Trials, where it shows an improvement of the dry eye symptoms made by the prostaglandins, reduction of the intraocullar eye preassure. The last Clinical Trial, published in 2023, showed a significant improve...

BRUDY LAB S.L.U. resources (1)